Sabina Sevcikova - Publications

Affiliations: 
Stanford University, Palo Alto, CA 

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Bezdekova R, Jelinek T, Kralova R, Stork M, Polackova P, Vsianska P, Brozova L, Jarkovsky J, Almasi M, Boichuk I, Knechtova Z, Penka M, Pour L, Sevcikova S, Hajek R, et al. Necessity of flow cytometry assessment of circulating plasma cells and its connection with clinical characteristics of primary and secondary plasma cell leukaemia. British Journal of Haematology. PMID 34500493 DOI: 10.1111/bjh.17713  1
2021 Krejci M, Pour L, Adam Z, Sandecka V, Stork M, Sevcikova S, Krejci M, Knechtova Z, Kral Z. Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience. Annals of Hematology. PMID 34309714 DOI: 10.1007/s00277-021-04594-w  1
2021 Jelinek T, Sevcikova T, Zihala D, Popkova T, Kapustova V, Broskevicova L, Capkova L, Rihova L, Bezdekova R, Sevcikova S, Zidlik V, Havel M, Plonkova H, Jungova A, Minarik J, et al. Limited efficacy of daratumumab in multiple myeloma with extramedullary disease. Leukemia. PMID 34247197 DOI: 10.1038/s41375-021-01343-w  1
2021 Gregorova J, Vychytilova-Faltejskova P, Sevcikova S. Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development. Cancers. 13. PMID 33809566 DOI: 10.3390/cancers13061333  1
2021 Stork M, Bezdekova R, Kralova R, Sandecka V, Adam Z, Krejci M, Boichuk I, Knechtova Z, Brozova L, Sevcikova S, Rihova L, Pour L. Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant. Neoplasma. PMID 33618517 DOI: 10.4149/neo_2021_200814N861  1
2020 Vrabel D, Sedlarikova L, Besse L, Rihova L, Bezdekova R, Almasi M, Kubaczkova V, Brožová L, Jarkovsky J, Plonkova H, Jelinek T, Sandecka V, Stork M, Pour L, Sevcikova S, et al. Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients. European Journal of Haematology. 104: 190-197. PMID 31763708 DOI: 10.1111/ejh.13358  1
2019 Sevcikova S, Minarik J, Stork M, Jelinek T, Pour L, Hajek R. Extramedullary disease in multiple myeloma - controversies and future directions. Blood Reviews. 36: 32-39. PMID 31005420 DOI: 10.1016/j.blre.2019.04.002  1
2019 Butova R, Vychytilova-Faltejskova P, Souckova A, Sevcikova S, Hajek R. Long Non-Coding RNAs in Multiple Myeloma. Non-Coding Rna. 5. PMID 30682861 DOI: 10.3390/ncrna5010013  1
2018 Steiner N, Hajek R, Sevcikova S, Borjan B, Untergasser G, Göbel G, Gunsilius E. The Plasma Levels of the Angiogenic Cytokine Endocan Are Elevated in Patients with Multiple Myeloma. Anticancer Research. 38: 5087-5092. PMID 30194153 DOI: 10.21873/anticanres.12828  1
2018 Sedlarikova L, Bollova B, Radova L, Brozova L, Jarkovsky J, Almasi M, Penka M, Kuglík P, Sandecká V, Stork M, Pour L, Sevcikova S. Circulating exosomal long noncoding RNA PRINS-First findings in monoclonal gammopathies. Hematological Oncology. 36: 786-791. PMID 30144133 DOI: 10.1002/hon.2554  1
2018 Steiner N, Müller U, Hajek R, Sevcikova S, Borjan B, Jöhrer K, Göbel G, Pircher A, Gunsilius E. The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets. Plos One. 13: e0202045. PMID 30096165 DOI: 10.1371/journal.pone.0202045  1
2017 Steiner N, Hajek R, Sevcikova S, Borjan B, Jöhrer K, Göbel G, Untergasser G, Gunsilius E. High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma. Plos One. 12: e0181487. PMID 28727816 DOI: 10.1371/journal.pone.0181487  1
2017 Kubaczkova V, Vrabel D, Sedlarikova L, Besse L, Sevcikova S. Cell-free DNA - Minimally invasive marker of hematological malignancies. European Journal of Haematology. 99: 291-299. PMID 28692178 DOI: 10.1111/ejh.12925  1
2017 Sedlarikova L, Gromesova B, Kubaczkova V, Radova L, Filipova J, Jarkovsky J, Brozova L, Velichova R, Almasi M, Penka M, Bezdekova R, Stork M, Adam Z, Pour L, Krejci M, ... ... Sevcikova S, et al. Deregulated expression of long non-coding RNA UCA1 in multiple myeloma. European Journal of Haematology. 99: 223-233. PMID 28543758 DOI: 10.1111/ejh.12908  1
2016 Besse L, Sedlarikova L, Greslikova H, Kupska R, Almasi M, Penka M, Jelinek T, Pour L, Adam Z, Kuglik P, Krejci M, Hajek R, Sevcikova S. Cytogenetics in multiple myeloma patients progressing into extramedullary disease. European Journal of Haematology. 97: 93-100. PMID 26432667 DOI: 10.1111/ejh.12688  1
2015 Stankova M, Kubaczkova V, Sedlarikova L, Sevcikova S. Circulating microRNA as Biomarkers in Hematological Malignancies. Exs. 106: 123-38. PMID 26608201 DOI: 10.1007/978-3-0348-0955-9_5  1
2015 Besse L, Sedlarikova L, Kryukov F, Nekvindova J, Radova L, Slaby O, Kuglik P, Almasi M, Penka M, Krejci M, Adam Z, Pour L, Sevcikova S, Hajek R. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma. Plos One. 10: e0137294. PMID 26389804 DOI: 10.1371/journal.pone.0137294  1
2015 Sevcikova S, Paszekova H, Besse L, Sedlarikova L, Kubaczkova V, Almasi M, Pour L, Hajek R. Extramedullary relapse of multiple myeloma defined as the highest risk group based on deregulated gene expression data. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 159: 288-93. PMID 25877407 DOI: 10.5507/bp.2015.014  1
2015 Kubiczkova Besse L, Sedlarikova L, Kryukov F, Nekvindova J, Radova L, Almasi M, Pelcova J, Minarik J, Pika T, Pikalova Z, Scudla V, Krejci M, Adam Z, Pour L, Hajek R, ... Sevcikova S, et al. Combination of serum microRNA-320a and microRNA-320b as a marker for Waldenström macroglobulinemia. American Journal of Hematology. 90: E51-2. PMID 25428891 DOI: 10.1002/ajh.23910  1
2015 Fiserova B, Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. The miR-29 family in hematological malignancies. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 159: 184-91. PMID 25004911 DOI: 10.5507/bp.2014.037  1
2015 Sedlarikova L, Kubiczkova L, Kryukov F, Pelcova J, Adam Z, Pour L, Hajek R, Sevcikova S. Detection of tumor-specific marker for minimal residual disease in multiple myeloma patients. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 159: 554-61. PMID 24993743 DOI: 10.5507/bp.2014.035  1
2014 Kubiczkova L, Pour L, Sedlarikova L, Hajek R, Sevcikova S. Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma. Journal of Cellular and Molecular Medicine. 18: 947-61. PMID 24712303 DOI: 10.1111/jcmm.12279  1
2014 Svachova H, Kryukov F, Kryukova E, Sevcikova S, Nemec P, Greslikova H, Rihova L, Kubiczkova L, Hajek R. Nestin expression throughout multistep pathogenesis of multiple myeloma. British Journal of Haematology. 164: 701-9. PMID 24329895 DOI: 10.1111/bjh.12689  1
2014 Kubiczkova L, Kryukov F, Slaby O, Dementyeva E, Jarkovsky J, Nekvindova J, Radova L, Greslikova H, Kuglik P, Vetesnikova E, Pour L, Adam Z, Sevcikova S, Hajek R. Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Haematologica. 99: 511-8. PMID 24241494 DOI: 10.3324/haematol.2013.093500  1
2014 Paszekova H, Kryukov F, Kubiczkova L, Hajek R, Sevcikova S. High-risk multiple myeloma: different definitions, different outcomes? Clinical Lymphoma, Myeloma & Leukemia. 14: 24-30. PMID 24225331 DOI: 10.1016/j.clml.2013.09.004  1
2014 Pour L, Sevcikova S, Greslikova H, Kupska R, Majkova P, Zahradova L, Sandecka V, Adam Z, Krejci M, Kuglik P, Hajek R. Soft-tissue extramedullary multiple myeloma prognosis is significantly worse in comparison to bone-related extramedullary relapse. Haematologica. 99: 360-4. PMID 24038024 DOI: 10.3324/haematol.2013.094409  1
2013 Kryukov F, Dementyeva E, Kubiczkova L, Jarkovsky J, Brozova L, Petrik J, Nemec P, Sevcikova S, Minarik J, Stefanikova Z, Kuglik P, Hajek R. Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia. Genomics. 102: 243-9. PMID 23831116 DOI: 10.1016/j.ygeno.2013.06.007  1
2013 Smardova J, Liskova K, Ravcukova B, Kubiczkova L, Sevcikova S, Michalek J, Svitakova M, Vybihal V, Kren L, Smarda J. High frequency of temperature-sensitive mutants of p53 in glioblastoma. Pathology Oncology Research : Por. 19: 421-8. PMID 23536279 DOI: 10.1007/s12253-012-9596-7  1
2013 Dementyeva E, Kryukov F, Kubiczkova L, Nemec P, Sevcikova S, Ihnatova I, Jarkovsky J, Minarik J, Stefanikova Z, Kuglik P, Hajek R. Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma. Journal of Translational Medicine. 11: 77. PMID 23522059 DOI: 10.1186/1479-5876-11-77  1
2013 Slaby O, Sachlova M, Brezkova V, Hezova R, Kovarikova A, Bischofová S, Sevcikova S, Bienertova-Vasku J, Vasku A, Svoboda M, Vyzula R. Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer. Nutrition and Cancer. 65: 247-54. PMID 23441612 DOI: 10.1080/01635581.2013.756530  1
2013 Kryukov F, Nemec P, Dementyeva E, Kubiczkova L, Ihnatova I, Budinska E, Jarkovsky J, Sevcikova S, Kuglik P, Hajek R. Molecular heterogeneity and centrosome-associated genes in multiple myeloma. Leukemia & Lymphoma. 54: 1982-8. PMID 23323949 DOI: 10.3109/10428194.2013.764416  1
2013 Smetana J, Berankova K, Zaoralova R, Nemec P, Greslikova H, Kupska R, Mikulasova A, Frohlich J, Sevcikova S, Zahradova L, Krejci M, Sandecka V, Almasi M, Kaisarova P, Melicharova H, et al. Gain(1)(q21) is an unfavorable genetic prognostic factor for patients with relapsed multiple myeloma treated with thalidomide but not for those treated with bortezomib. Clinical Lymphoma, Myeloma & Leukemia. 13: 123-30. PMID 23291040 DOI: 10.1016/j.clml.2012.11.012  1
2013 Omidvar N, Maunakea ML, Jones L, Sevcikova S, Yin B, Himmel KL, Tennant TR, Le Beau MM, Largaespada DA, Kogan SC. PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice. Haematologica. 98: 424-7. PMID 23144197 DOI: 10.3324/Haematol.2011.057067  1
2013 Sevcikova S, Kubiczkova L, Sedlarikova L, Slaby O, Hajek R. Serum miR-29a as a marker of multiple myeloma. Leukemia & Lymphoma. 54: 189-91. PMID 22712836 DOI: 10.3109/10428194.2012.704030  1
2012 Buresova I, Cumova J, Kovarova L, Stossova J, Dementyeva E, Kryukov F, Sevcikova S, Svachova H, Hajek R. Bone marrow plasma cell separation - validation of separation algorithm. Clinical Chemistry and Laboratory Medicine. PMID 23095232 DOI: 10.1515/cclm-2011-0837  1
2012 Kubiczkova L, Sedlarikova L, Hajek R, Sevcikova S. TGF-β - an excellent servant but a bad master. Journal of Translational Medicine. 10: 183. PMID 22943793 DOI: 10.1186/1479-5876-10-183  1
2012 Sedlarikova L, Kubiczkova L, Sevcikova S, Hajek R. Mechanism of immunomodulatory drugs in multiple myeloma. Leukemia Research. 36: 1218-24. PMID 22727252 DOI: 10.1016/j.leukres.2012.05.010  1
2012 Buresova I, Cumova J, Kovarova L, Stossova J, Dementyeva E, Kryukov F, Sevcikova S, Svachova H, Hajek R. Bone marrow plasma cell separation - validation of separation algorithm. Clinical Chemistry and Laboratory Medicine. 50: 1139-40. PMID 22706262 DOI: 10.1515/cclm-2012-8837  1
2012 Faltejskova P, Besse A, Sevcikova S, Kubiczkova L, Svoboda M, Smarda J, Kiss I, Vyzula R, Slaby O. Clinical correlations of miR-21 expression in colorectal cancer patients and effects of its inhibition on DLD1 colon cancer cells. International Journal of Colorectal Disease. 27: 1401-8. PMID 22476768 DOI: 10.1007/s00384-012-1461-3  1
2011 Almasi M, Sevcikova S, Slaby O, Kaisarova P, Maisnar V, Penka M, Pika T, Pour L, Radocha J, Scudla V, Svachova H, Hajek R. Association study of selected genetic polymorphisms and occurrence of venous thromboembolism in patients with multiple myeloma who were treated with thalidomide. Clinical Lymphoma, Myeloma & Leukemia. 11: 414-20. PMID 21859556 DOI: 10.1016/j.clml.2011.03.024  1
2011 Kryukov F, Dementyeva E, Smetana J, Sevcikova S, Kuglik P, Hajek R. Association of aneuploidy category with centrosome amplification in multiple myeloma. Leukemia & Lymphoma. 52: 2020-2. PMID 21635202 DOI: 10.3109/10428194.2011.587561  1
2010 Jones L, Wei G, Sevcikova S, Phan V, Jain S, Shieh A, Wong JC, Li M, Dubansky J, Maunakea ML, Ochoa R, Zhu G, Tennant TR, Shannon KM, Lowe SW, et al. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. The Journal of Experimental Medicine. 207: 2581-94. PMID 21059853 DOI: 10.1084/Jem.20091071  1
2007 Lee BD, Sevcikova S, Kogan SC. Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice. Leukemia Research. 31: 1131-4. PMID 17184839 DOI: 10.1016/j.leukres.2006.11.012  1
0 Almasi M, Besse L, Brozova L, Jarkovsky J, Bezdekova R, Pour L, Minarik J, Kessler P, Pavlíček P, Roziakova L, Penka M, Hájek R, Vasku A, Sevcikova S. Selected Genetic Polymorphisms Associated with Hypoxia and Multidrug Resistance in Monoclonal Gammopathies Patients. Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti. 31: 213-229. PMID 30441975 DOI: 10.14735/amko2018213  1
Show low-probability matches.